Information Journal Paper
APA:
Copy. (2019). Rituximab versus cyclophosphamide for the treatment of children with steroid resistance nephrotic syndrome; a clinical trial study. IMMUNOPATHOLOGIA PERSA, 5(2), 1-5. SID. https://sid.ir/paper/739755/en
Vancouver:
Copy. Rituximab versus cyclophosphamide for the treatment of children with steroid resistance nephrotic syndrome; a clinical trial study. IMMUNOPATHOLOGIA PERSA[Internet]. 2019;5(2):1-5. Available from: https://sid.ir/paper/739755/en
IEEE:
Copy, “Rituximab versus cyclophosphamide for the treatment of children with steroid resistance nephrotic syndrome; a clinical trial study,” IMMUNOPATHOLOGIA PERSA, vol. 5, no. 2, pp. 1–5, 2019, [Online]. Available: https://sid.ir/paper/739755/en